论文部分内容阅读
代谢综合征(MS)是一组由环境因素与遗传因素共同决定的,以胰岛素抵抗为中心环节的一组代谢紊乱疾病,包括中心型肥胖、高血脂、高血压及血糖代谢异常综合征。微量白蛋白尿(MA)为肾损伤的初始标志,MS常常伴有MA。本文通过研究降钙素基因相关肽(CGRP)和同型半胱氨酸(Hcy)在MS合并MA发展过程中的作用及羟苯磺酸钙和缬沙坦联合治疗前后MS合并MA患者CGRP和Hcy水平
Metabolic syndrome (MS) is a group of metabolic disorders with insulin resistance as the central component, a combination of environmental factors and genetic factors, including central obesity, hyperlipidemia, hypertension and glycometabolic syndrome. Microalbuminuria (MA) is the initial sign of renal injury, MS is often accompanied by MA. This study was to investigate the role of calcitonin gene related peptide (CGRP) and homocysteine (Hcy) in the development of MS combined with MA and the relationship between CGRP and Hcy in patients with MS and MA before and after combination of calcium dobesilate and valsartan Level